Clinical trial
Efavirenz Versus Rilpivirine on Vascular Function, Inflammation, and Oxidative Stress
NCT01585038
Study timeline
Study start (unknown)2012-07-01Date precision: month
Registry last updated2015-08-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Cardiovascular Diseaseunresolved
Interventions
EfavirenzDRUG · verified · RxNorm: efavirenz
RilpivirineDRUG · verified · RxNorm: rilpivirine
Sponsors & collaborators
Indiana Universitylead sponsor
Janssen Services, LLCcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01585038 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.